Correlation Between Dogwood Therapeutics, and Opus Genetics,

Can any of the company-specific risk be diversified away by investing in both Dogwood Therapeutics, and Opus Genetics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dogwood Therapeutics, and Opus Genetics, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Dogwood Therapeutics, and Opus Genetics,, you can compare the effects of market volatilities on Dogwood Therapeutics, and Opus Genetics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dogwood Therapeutics, with a short position of Opus Genetics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dogwood Therapeutics, and Opus Genetics,.

Diversification Opportunities for Dogwood Therapeutics, and Opus Genetics,

0.72

Correlation Coefficient

Dogwood Therapeutics,  Opus Genetics,

Poor diversification

The 3 months correlation between Dogwood and Opus is 0.72. Overlapping area represents the amount of risk that can be diversified away by holding Dogwood Therapeutics, and Opus Genetics, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Opus Genetics, and Dogwood Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dogwood Therapeutics, are associated (or correlated) with Opus Genetics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Opus Genetics, has no effect on the direction of Dogwood Therapeutics, i.e., Dogwood Therapeutics, and Opus Genetics, go up and down completely randomly.

Pair Corralation between Dogwood Therapeutics, and Opus Genetics,

Given the investment horizon of 90 days Dogwood Therapeutics, is expected to under-perform the Opus Genetics,. In addition to that, Dogwood Therapeutics, is 2.42 times more volatile than Opus Genetics,. It trades about -0.03 of its total potential returns per unit of risk. Opus Genetics, is currently generating about 0.0 per unit of volatility. If you would invest  119.00  in Opus Genetics, on September 2, 2024 and sell it today you would lose (8.00) from holding Opus Genetics, or give up 6.72% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Dogwood Therapeutics,  vs.  Opus Genetics,

Dogwood Therapeutics,

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Dogwood Therapeutics, has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Opus Genetics,

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Opus Genetics, has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Opus Genetics, is not utilizing all of its potentials. The recent stock price tumult, may contribute to shorter-term losses for the shareholders.

Pair Trading with Dogwood Therapeutics, and Opus Genetics,

The main advantage of trading using opposite Dogwood Therapeutics, and Opus Genetics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dogwood Therapeutics, position performs unexpectedly, Opus Genetics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Opus Genetics, will offset losses from the drop in Opus Genetics,'s long position.

The idea behind Dogwood Therapeutics, and Opus Genetics, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.